PROVERA, ALESSIA
 Distribuzione geografica
Continente #
EU - Europa 109
NA - Nord America 41
AS - Asia 13
AF - Africa 3
Totale 166
Nazione #
IT - Italia 44
US - Stati Uniti d'America 41
IE - Irlanda 33
DE - Germania 12
SE - Svezia 11
IN - India 6
SG - Singapore 5
BE - Belgio 3
EG - Egitto 2
GB - Regno Unito 2
NL - Olanda 2
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
NG - Nigeria 1
PK - Pakistan 1
Totale 166
Città #
Dublin 29
Turin 11
Chandler 9
Piemonte 6
Ashburn 4
Bulandshahr 4
Milan 4
Ann Arbor 3
Berlin 3
Bremen 3
Brussels 3
Singapore 3
Vercelli 3
Amsterdam 2
Bologna 2
Cairo 2
Cincinnati 2
Des Moines 2
Lawrence 2
Novara 2
Padova 2
Princeton 2
Woodbridge 2
Altavilla Monferrato 1
Brno 1
Grafing 1
Lahore 1
Leawood 1
Monmouth Junction 1
Mülheim 1
Nagpur 1
Newcastle upon Tyne 1
Norwalk 1
Senden 1
Shimosakunobe 1
Slough 1
Strasbourg 1
Wilmington 1
Totale 120
Nome #
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 69
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 53
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 36
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 6
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 4
Characterization of Novel Targets for Preventing Fibrosis Evolution in Nonalcoholic Fatty Liver Disease (NAFLD) 4
Totale 172
Categoria #
all - tutte 1.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202240 0 0 0 0 0 13 6 0 6 2 9 4
2022/202392 8 3 6 4 6 15 6 2 30 1 7 4
2023/202435 0 5 0 0 3 2 8 1 2 3 6 5
2024/20255 1 4 0 0 0 0 0 0 0 0 0 0
Totale 172